REFERENCES
- Biegel L. B., Hurtt M. E., Frame S. R., O'Connor J. C., Cook J. C. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci 2001; 60: 44–55, [INFOTRIEVE], [CSA]
- Butenhoff J., Costa G., Elcombe C., Farrar D., Hansen K., Iwai H., Jung R., Kennedy G., Jr., Lieder P., Olsen G., Thomford P. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol. Sci 2002; 69: 244–257, [INFOTRIEVE], [CSA], [CROSSREF]
- Cattley R. C., DeLuca J., Elcombe C., Fenner-Crisp P., Lake B. G., Marsman D. S., Pastoor T. A., Popp J. A., Robinson D. E., Schwetz B., Tugwood J., Wahli W. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?. Regul. Toxicol. Pharmacol 1998; 27: 47–60, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Corton J. C., Anderson S. P., Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Ann. Rev. Pharmacol. Toxicol 2000; 40: 491–518, [CSA], [CROSSREF]
- Cunard R., DiCampli D., Archer D. C., Stevenson J. L., Ricote M., Glass C. K., Kelly C. J. WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo. J. Immunol 2002; 169: 6806–6812, [INFOTRIEVE], [CSA]
- Jones D. C., Ding X., Daynes R. A. Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J. Biol. Chem 2002; 277: 6838–6845, [INFOTRIEVE], [CSA], [CROSSREF]
- Kennedy G. L., Jr. Increase in mouse liver weight following feeding of ammonium perfluorooctanoate and related fluorochemicals. Toxicol. Lett 1987; 39: 295–300, [INFOTRIEVE], [CSA], [CROSSREF]
- Kennedy G. L., Jr., Butenhoff J. L., Olsen G. W., O'Connor J. C., Seacat A. M., Perkins R. G., Biegel L. B., Murphy S. R., Farrar D. G. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol 2004; 34: 351–384, [INFOTRIEVE], [CSA], [CROSSREF]
- Kudo N., Bandai N., Suzuki E., Katakura M., Kawashima Y. Induction by perfluorinated fatty acids with different carbon chain length of peroxisomal beta-oxidation in the liver of rats. Chem. Biol. Interact 2000; 124: 119–132, [INFOTRIEVE], [CSA], [CROSSREF]
- Kurata Y., Kidachi F., Yokoyama M., Toyota N., Tsuchitani M., Katoh M. Subchronic toxicity of Di(2-ethylhexyl)phthalate in common marmosets: lack of hepatic peroxisome proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia. Toxicol. Sci 1998; 42: 49–56, [INFOTRIEVE], [CSA], [CROSSREF]
- Lazarow P. B., De Duve C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc. Natl. Acad. Sci. U.S.A 1976; 73: 2043–2046, [INFOTRIEVE], [CSA]
- Markwell M. A., McGroarty E. J., Bieber L. L., Tolbert N. E. The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. A new peroxisomal enzyme. J. Biol. Chem 1973; 248: 3426–3432, [INFOTRIEVE], [CSA]
- Nelson D. L., Frazier D. E., Jr., Ericson J. E., Tarr M. J., Mathes L. E. The effects of perfluorodecanoic acid (PFDA) on humoral, cellular, and innate immunity in Fischer 344 rats. Immunopharmacol. Immunotoxicol 1992; 14: 925–938, [INFOTRIEVE], [CSA]
- Pugh G., Jr., Isenberg J. S., Kamendulis L. M., Ackley D. C., Clare L. J., Brown R., Lington A. W., Smith J. H., Klaunig J. E. Effects of di-isononyl phthalate, di-2‐ethylhexyl phthalate, and clofibrate in cynomolgus monkeys. Toxicol. Sci 2000; 56: 181–188, [INFOTRIEVE], [CSA], [CROSSREF]
- Takagi A., Sai K., Umemura T., Hasegawa R., Kurokawa Y. Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators. J. Environ. Pathol. Toxicol. Oncol 1992; 11: 145–149, [INFOTRIEVE], [CSA]
- Yang Q., Xie Y., Depierre J. W. Effects of peroxisome proliferators on the thymus and spleen of mice. Clin. Exp. Immunol 2000; 122: 219–226, [INFOTRIEVE], [CSA], [CROSSREF]
- Yang Q., Xie Y., Eriksson A. M., Nelson B. D., DePierre J. W. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochem. Pharmacol 2001; 62: 1133–1140, [INFOTRIEVE], [CSA], [CROSSREF]
- Yang Q., Xie Y., Alexson S. E., Nelson B. D., DePierre J. W. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem. Pharmacol 2002; 63: 1893–1900, [INFOTRIEVE], [CSA], [CROSSREF]